Cas:99902-70-2 6-(4-chlorophenoxy)pyridine-3-carbonitrile manufacturer & supplier

We serve Chemical Name:6-(4-chlorophenoxy)pyridine-3-carbonitrile CAS:99902-70-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

6-(4-chlorophenoxy)pyridine-3-carbonitrile

Chemical Name:6-(4-chlorophenoxy)pyridine-3-carbonitrile
CAS.NO:99902-70-2
Synonyms:hms566g08
Molecular Formula:C12H7ClN2O
Molecular Weight:230.65000
HS Code:2933399090

Physical and Chemical Properties:
Melting point:129-131ºC
Boiling point:369.9ºC at 760mmHg
Density:1.35g/cm3
Index of Refraction:1.626
PSA:45.91000
Exact Mass:230.02500
LogP:3.39898

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like hms566g08 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,hms566g08 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,hms566g08 Use and application,hms566g08 technical grade,usp/ep/jp grade.


Related News: In addition, AstraZeneca is exploring the potential of anifrolumab in a variety of diseases where type I interferon plays a key role, including lupus nephritis, cutaneous lupus erythematosus and myositis. 4-Ethylcyclohexanecarboxylic acid manufacturers Officials did, however, acknowledge that there’s growing evidence an extra jab may enhance the antibody response in immunocompromised people. Some small studies suggest up to 50% of people with no antibody response after the authorized regimen of two mRNA jabs developed a response after an additional dose, said CDC’s Sara Oliver, M.D. 2-(Diphenylmethoxy)propanenitrile suppliers “The most important thing to be considered while determining a CDMO competency is their technical knowledge along with adequate expertise to accomplish the drug development till commercial scaling. mercury(1+),2,2,2-trifluoroacetate vendor & factory.